| |
CVD
|
Hard CVD
|
CHD
|
Hard CHD
|
|---|
|
HR (95%CI)
|
P-value
|
HR (95%CI)
|
P-value
|
HR (95%CI)
|
P-value
|
HR (95%CI)
|
P-value
|
|---|
|
FPG
|
|
Model 1
|
1.21 (1.09–1.34)
|
< 0.001
|
1.27 (1.08–1.49)
|
0.004
|
1.15 (1.03–1.29)
|
0.01
|
1.22 (0.99–1.49)
|
0.06
|
|
Model 2
|
1.20 (1.08–1.34)
|
0.001
|
1.27 (1.07–1.51)
|
0.006
|
1.15 (1.02–1.29)
|
0.02
|
1.25 (1.00–1.56)
|
0.05
|
|
2 h-PCPG
|
|
Model 1
|
1.21 (1.08–1.36)
|
0.001
|
1.21 (1.01–1.45)
|
0.04
|
1.17 (1.03–1.32)
|
0.01
|
1.20 (0.96–1.51)
|
0.11
|
|
Model 2
|
1.21 (1.07–1.36)
|
0.002
|
1.21 (0.99–1.47)
|
0.06
|
1.16 (1.03–1.32)
|
0.02
|
1.23 (0.96–1.57)
|
0.10
|
- CVD cardiovascular disease, CHD coronary heart disease, HR hazard ratio, CI confidence interval, FPG fasting plasma glucose, 2 h-PCPG 2 h post challenge plasma glucose
- Model 1: age and sex
- Model 2: model 1 + body mass index, current smoking, family history of premature CVD, hypertension, hypercholesterolemia, low HDL-C, heart rate, use of aspirin, use of beta blockers and low physical activity
